Expression and possible roles of activin A in proliferative vitreoretinal diseases

Japanese Journal of Ophthalmology

Volumn 44, Issue 3, 2000, Pages 221-226

  Yamamoto, Teiko ^a   Takeuchi, Shinobu ^a   Suzuki, Kiyoka ^a   Yamashita, Hidetoshi ^b  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Activin A; Activin receptors; Diabetic retinopathy; Proliferative membranes; Vitreoretinal diseases

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RETINA ISCHEMIA; VITREORETINOPATHY;

ACTIVIN RECEPTORS; ACTIVINS; ADULT; AGED; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; EPIRETINAL MEMBRANE; FEMALE; FIBROBLASTS; HUMANS; INHIBINS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, GROWTH FACTOR; RETINAL PERFORATIONS; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0034612170     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(99)00216-6     Document Type: Article

References (26)

1. Michaelson I.C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Vis Sci. 68:1948;137-180.
2. Paster J.C. Proliferative vitreoretinopathy. an overview Surv Ophthalmol. 43:1998;3-18.
3. Casey R., Li W.W. Factors controlling ocular angiogenesis. Am J Ophthalmol. 124:1997;521-529.
4. Frank R.N. Vascular endothelial growth factor - its role in retinal vascular proliferation. N Engl J Med. 331:1994;1519-1520.
5. Sharp P.S. The role of growth factors in the development of diabetic retinopathy. Metabolism. 44(Suppl 4):1995;72-75.
6. D'Amore P. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 35:1994;3974-3979.
7. Miyazono K., ten Dijke P., Ichijo H., Heldin C.-H. Receptors for transforming growth factor-β Adv Immunol. 55:1994;181-220.
8. Yang E.Y., Moses H.L. Transforming growth factor β1-induced changes in cell migration and angiogenesis in the chicken chorio-allantoic membrane. J Cell Biol. 111:1990;731-741.
9. Pepper M.S., Vassalli J.-D., Orci L., Montesano R. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res. 204:1993;356-363.
10. Pepper M.S. Transforming growth factor-β vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev. 8:1997;21-43.
11. Mathews L.S. Activin receptors and cellular signaling by the receptor serine kinase family. Endocrine Rev. 15:1994;310-325.
12. McCarthy S.A., Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem. 268:1993;23066-23071.
13. Kozian D.H., Ziche M., Augustin H.G. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest. 76:1997;267-276.
14. Yamashita H., Shimizu A., Kato M., Nishidoh H., Ichijo H., Miyazono K. Regulation of angiogenesis by TGF-β superfamily. Aono T., Sugino H., Vale W.W. Inhibin, activin and follistatin. Regulatory functions in system and cell biology. 1997;312-314 Springer-Verlag, New York.
15. Matuse T., Ikegami A., Ohga E.et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol. 148:1996;707-713.
16. Ohaga E., Matsuse T., Teramoto S.et al. Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun. 228:1996;391-396.
17. Hübner G., Hu Q., Smola H., Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol. 173:1996;490-498.
18. Jaffe G.J., Harrison C.E., Lui G.M.et al. Activin expression by cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 35:1994;2924-2931.
19. Obata H., Kaji Y., Kaburaki T.et al. Expression of transforming growth factor-β (TGF-β) type I receptor family in ocular tissue. Invest Ophthalmol Vis Sci. 38(Suppl):1996;S862.
20. Eto Y., Tsuji T., Takezawa M., Takano S., Yokogawa Y., Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun. 142:1987;1095-1103.
21. Furukawa M., Eto Y., Kojima I. Expression of immunoreactive activin A in fetal rat pancreas. Endocrine J. 42:1995;63-68.
22. Ichijo H., Yamashita H., ten Dijke P., Eto Y., Heldin C.-H., Miyazono K. Characterization of in vivo phosphorylation of activin type II receptor. Biochem Biophys Res Commun. 194:1993;1508-1514.
23. ten Dijke P., Yamashita H., Ichijo H., Franzèn P., Miyazono K., Heldin C.-H. Characterization of type I receptors for transforming growth-β and activin. Science. 264:1994;101-104.
24. Yamashita H., ten Dijke P., Heldin C.-H., Miyazono K. Bone morphogenetic protein receptors. Bone. 19:1996;569-574.
25. Heldin C.-H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
26. Hübner G., Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res. 228:1996;106-113.